From the latest Newsletter:

Blog

White Papers

SphygmoCor®

Visit Our Booth at the A4M Anti-Aging Conference This Weekend

Stop by Booth 4033 to learn how ATCOR’s SphygmoCor® XCEL will help you personalize hypertension management for your patients. In addition, to help you acquire our gold-standard noninvasive central blood pressure measurement technology, we are offering an attractive lease program with a 90-day risk-free guarantee.

CardieX and Mobvoi preparing for commercial launch of new smartwatch with advanced heart health features in US and Australia

The two global companies announce imminent release of first-in-kind smartwatch.

CardieX and Mobvoi are excited to announce significant progress towards commercialization and launch of a new smartwatch with first-in-class, advanced heart health features developed by ATCOR, a subsidiary of the Company.

Pursuant to announcing their new commercial partnership in September 2020, the two companies have been working closely to develop a new consumer smartwatch under the Mobvoi brand with the Company’s proprietary Arty® Heart Health analytics platform, which is an advanced heart and arterial health management ecosystem that leverages the Company’s FDA-cleared gold standard SphygmoCor® technology for measuring central arterial pressure waveforms.

The new smartwatch will be the first in the world to feature Arty® Score, Exercise Capacity® (eCAP®), ArtyAge®, Heart Stress Score (HSS), and TruHR® – unique features enabled by the Arty® Heart Health analytics platform. Mobvoi has been leading the development of hardware and firmware, while ATCOR has been focused on integration of proprietary Arty® Heart Health algorithms.

“It is incredibly exciting to see the significant progress that we have made with the Mobvoi team to bring a unique and differentiated feature set focused on heart health into Mobvoi’s portfolio”, said Craig Cooper, CEO and Managing Director of CardieX. “I am very happy that we decided to further development efforts during the pandemic instead of launching early, and we are even more confident now that the improvements we have made will make this one of Mobvoi’s most exciting consumer smartwatch launches.”

“We are tremendously excited about the progress that our teams have made during this initial partnership with CardieX and ATCOR,” said Zhifei Li, CEO of Mobvoi. “The imminent launch of our new smartwatch will provide a glimpse of the Arty® Heart Health capabilities and importantly represent
Mobvoi’s commitment to health-focused features in its consumer electronics portfolio.”